Merck KGaA (XSWX:MER)
CHF 223 0 (0%) Market Cap: 77.56 Bil Enterprise Value: 86.30 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 90/100

Merck KGaA R&D Update Call Transcript

Jun 14, 2019 / 11:30AM GMT
Release Date Price: CHF101.7
Operator

Welcome to the Merck R&D update call 2019.

(Operator Instructions) Please note that our customer request this conference call will be recorded. (Operator Instructions)

Thank you for holding. Dear ladies and gentlemen, welcome to the Merck R&D update call 2019. (Operator Instructions).

May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Very warm welcome. Thank you, Cynthia, a warm welcome to this R&D update call 2019. My name is Constantin Fest, Head of Investor Relations. And I'm delighted to have with me here today Luciano Rossetti as well as Rehan Verjee. Luciano, our Global Head of Research and Development; Rehan, President of EMD Serono and Global Head of Innovative Medicine franchises. And also, I'm very happy that supporting for the Q&A, we also have Joern-Peter Halle, Head of External Innovation and Head of TIP Immuno Oncology here with us. And in the next

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot